Señales en vivo de AVE.AX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 01:45):

Stats
Volumen de hoy	484 448
Volumen promedio	5.20M
Capitalización de mercado	12.68M
EPS	$0 ( 2024-02-27 )
Próxima fecha de ganancias	( $0 ) 2024-05-30
Last Dividend	$0.00878 ( 1997-05-19 )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Volumen Correlación

Largo: -0.43 (neutral)

Corto: 0.00 (neutral)

Signal:(53.067) Neutral

Avecho Biotechnology Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avecho Biotechnology Ltd Correlación - Moneda/Commodity

0.00
( neutral )

Avecho Biotechnology Ltd Finanzas

Annual	2023
Ingresos:	$473 551
Beneficio Bruto:	$-222 490 (-46.98 %)
EPS:	$-0.00150

FY	2023
Ingresos:	$473 551
Beneficio Bruto:	$-222 490 (-46.98 %)
EPS:	$-0.00150

FY	2022
Ingresos:	$1.13M
Beneficio Bruto:	$793 118 (70.23 %)
EPS:	$-0.00130

FY	2021
Ingresos:	$1.06M
Beneficio Bruto:	$677 486 (63.94 %)
EPS:	$-0.00324

Financial Reports:

No articles found.

Avecho Biotechnology Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Avecho Biotechnology Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.00878	1997-05-19
Last Dividend	$0.00878	1997-05-19
Next Dividend	$0	N/A
Payout Date	1997-06-06
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.00878	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-04)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
RMC.AX	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
BTI.AX	Ex Dividend Junior	2023-08-21	Sporadic	0.00%
LNK.AX	Ex Dividend Junior	2023-09-05	Semi-Annually	0.00%
SXE.AX	Ex Dividend Knight	2023-09-26	Annually	0.00%
CQE.AX	Ex Dividend Knight	2023-09-28	Quarterly	0.00%
NBI.AX	Ex Dividend Knight	2023-09-01	Bi-Monthly	0.00%
WOR.AX	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
EVN.AX	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
PIA.AX	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
ANN.AX	Ex Dividend Knight	2023-08-18	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-7.26	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.470	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.802	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	8.30	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.83	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	6.53	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0239	-1.500	9.60	-10.00	[0 - 0.6]
interestCoverageTTM	-298.85	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.00100	2.00	-0.000334	-0.000669	[0 - 30]
freeCashFlowPerShareTTM	-0.00100	2.00	-0.000502	-0.00100	[0 - 20]
debtEquityRatioTTM	0.0275	-1.500	9.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	-0.470	1.000	-10.00	-10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-9.69	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-18.16	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.0647	0.800	-2.90	-2.32	[0.5 - 2]
Total Score				-2.73

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-3.69	1.000	-0.474	0	[1 - 100]
returnOnEquityTTM	-0.802	2.50	-6.44	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00100	2.00	-0.000334	-0.00100	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00100	2.00	-0.000334	-0.000669	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.115	1.500	-2.57	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-6.72	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.43

Avecho Biotechnology Ltd

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.